logo

DAVA

Endava·NYSE
--
--(--)
--
--(--)
3.83 / 10
Netural

DAVA's fundamental health is moderate (score 3.8/10). Strengths include positive Revenue-MV and Profit-MV, while weaknesses are seen in Inventory turnover days and ROE. The asset-liability ratio is favorable, but overall, the company appears more defensive than growth-oriented, limiting upside potential.

Fundamental(3.83)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value1.24
Score2/3
Weight4.84%
1M Return1.68%
Asset-liability ratio (%)
Value37.70
Score3/3
Weight15.24%
1M Return5.78%
Annualized return on equity (%)
Value3.47
Score1/3
Weight2.62%
1M Return0.99%
Operating cycle
Value93.98
Score1/3
Weight1.49%
1M Return0.56%
Profit-MV
Value0.46
Score3/3
Weight13.50%
1M Return4.40%
Interest coverage ratio (EBIT / Interest expense) (%)
Value4.26
Score2/3
Weight3.78%
1M Return1.48%
Asset-MV
Value0.47
Score2/3
Weight46.84%
1M Return12.18%
ROE (%)
Value3.47
Score1/3
Weight2.62%
1M Return0.99%
Inventory turnover days
Value300.47
Score1/3
Weight3.31%
1M Return1.30%
Cash-MV
Value0.34
Score1/3
Weight5.78%
1M Return1.98%
Is DAVA undervalued or overvalued?
  • DAVA scores 3.83/10 on fundamentals and holds a Fair valuation at present. Backed by its -1.42% ROE, 1.46% net margin, 10.19 P/E ratio, 0.39 P/B ratio, and 45.88% earnings growth, these metrics solidify its Netural investment rating.